Is drug-resistant partial epilepsy progressive?;¿Es progresiva la epilepsia parcial farmacorresistente?

Revista de Neurologia

Volumn 34, Issue 6, 2002, Pages 505-510

  Elices, E ^a   Arroyo, S ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Drug resistant epilepsy; Magnetic resonance imaging; Natural history; Partial epilepsy; Progression; Temporal lobe epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; NEUROPROTECTIVE AGENT;

ARTICLE; COGNITIVE DEFECT; EXPERIMENTAL MODEL; FOCAL EPILEPSY; HUMAN; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TEMPORAL LOBE EPILEPSY; DRUG RESISTANCE; DRUG TOLERANCE; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY;

ANTICONVULSANTS; COGNITION DISORDERS; DRUG RESISTANCE; DRUG TOLERANCE; EPILEPSIES, PARTIAL; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0037117058     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3406.2001360     Document Type: Article

References (53)

1. The role of secondary epileptogenesis in human epilepsy
2. Long-term clinical and EEG changes in patients with epilepsy
3. Mirror focus: Function of seizure frequency and influence on outcome after surgery
4. Seizure outcome after temporal lobectomy for temporal lobe epilepsy: A Kaplan-Meier survival analysis
5. Is partial epilepsy progressive? Ten-year follow-up of EEG and neuropsychological changes in adults with partial seizures
6. Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya
7. Some aspects of prognosis in the epilepsies: A review
8. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: Meta-analysis of controlled trials
9. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
10. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy
11. Does antiepileptic drug therapy prevent the development of 'chronic' epilepsy?
12. The course of untreated epilepsy
13. Clinical course of untreated tonic-clonic seizures in childhood: Prospective, hospital based study
14. Early identification of refractory epilepsy
15. Clinical aspects and biological bases of drug-resistant epilepsies
16. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less
17. Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy
18. Neuropsychological effects of epilepsy and antiepileptic drugs
19. Volumetric MRI, pathological, and neuropsychological progression in hippocampal sclerosis
20. Cognitive deficits in epilepsy and contribution to psychopathology
21. Verbal memory in newly diagnosed patients and patients with chronic left temporal lobe epilepsy
22. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy
23. Quantitative magnetic resonance imaging in temporal lobe epilepsy: Relationship to neuropathology and neuropsychological function
24. 2 relaxation time in the evaluation of mesial temporal lobe epilepsy: Correlation with clinical severity and memory performances
25. The neural substrate of memory impairment demonstrated by the intracarotid amobarbital procedure
26. Phenobarbital for febrile seizures: Effects on intelligence and on seizure recurrence
27. Entorhinal cortex atrophy in epilepsy patients exhibiting normal hippocampal volumes
28. Seizure-induced transient hippocampal abnormalities on MR: Correlation with positron emission tomography and electroencephalography
29. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions
30. Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis
31. Is the underlying cause of epilepsy a major prognostic factor for recurrence?
32. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?
33. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy
34. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy
35. Atrophy of mesial structures in patients with temporal lobe epilepsy: Cause or consequence of repeated seizures?
36. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy
37. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures
38. Hippocampal damage caused by seizures in temporal lobe epilepsy
39. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy
40. Usefulness of proton MR spectroscopy in the evaluation of temporal lobe epilepsy
41. Magnetic resonance spectroscopy in temporal lobe epilepsy
42. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy
43. Medial temporal lobe neuronal damage in temporal and extratemporal lesional epilepsy
44. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy
45. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging
46. Is epilepsy a progressive disease? The neurobiological consequences of epilepsy
47. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
48. Topiramate blocks perinatal hypoxia-induced seizures in rat pups
49. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy
50. Multidrug-resistance protein 1 in focal cortical dysplasia
51. MDR1 gene expression in brain of patients with medically intractable epilepsy
52. Cellular pump changes prospect of disease resistance